Lite Strategy, Inc. (LITS)
0.9758
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
0.9758
0.00 (0.00%)
After-Hours: 20:00
Lite Strategy Cash from Operations (Annual) : -20.84M for June 30, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| June 30, 2025 | -20.84M |
| June 30, 2024 | -50.68M |
| June 30, 2023 | -52.48M |
| June 30, 2022 | -48.75M |
| June 30, 2021 | -31.96M |
| June 30, 2020 | 34.26M |
| June 30, 2019 | -29.42M |
| June 30, 2018 | -21.30M |
| June 30, 2017 | 3.486M |
| June 30, 2016 | -17.86M |
| June 30, 2015 | -28.07M |
| June 30, 2014 | -19.45M |
| Date | Value |
|---|---|
| June 30, 2013 | -10.04M |
| June 30, 2012 | -7.487M |
| June 30, 2011 | -6.501M |
| June 30, 2010 | -10.03M |
| June 30, 2009 | -10.55M |
| June 30, 2008 | -11.50M |
| June 30, 2007 | -10.79M |
| June 30, 2006 | -9.089M |
| June 30, 2005 | -5.581M |
| June 30, 2004 | -7.972M |
| June 30, 2003 | -1.841M |
| June 30, 2002 | -0.004M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.39M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |